Body Mass Index

---

VIVUS Announces Qsymia Presentations at Obesity Week 2014 Posted: 03 Nov 2014 04:00 AM PST VIVUS, Inc. , a biopharmaceutical company commercializing Qsymia® capsules CIV for the treatment of obesity, today announced the following presentations at Obesity Week 2014, Boston...

Type 1 Diabetes Market for Diagnosed Prevalent Cases to Grow 40.40% to 2023 Says a New Report Available at RnRMarketResearch.com Posted: RnRMarketResearch.com adds "EpiCast Report: Type 1 Diabetes – Epidemiology Forecast to 2023" to its store. Epidemiologists forecast an increase in the diagnosed prevalent cases of type 1 diabetes in the 8MM. (PRWeb November 03, 2014) Read the full story at This posting includes an audio/video/photo media file: Download Now

You are subscribed to email updates from Content Keyword RSS copy copy copy To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States